In CRC, c-MYC has been found to be overexpressed in up to 80% of sporadic cases—a result of its transcriptional activation mediated by β-catenin following APC inactivation and its post-translational stabilization mediated by ERK [10]. Here, MYC is linked to colorectal carcinoma.